These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34123867)

  • 21. Restoration of cefixime-induced gut microbiota changes by Lactobacillus cocktails and fructooligosaccharides in a mouse model.
    Shi Y; Zhai Q; Li D; Mao B; Liu X; Zhao J; Zhang H; Chen W
    Microbiol Res; 2017 Jul; 200():14-24. PubMed ID: 28527760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice.
    Chitrala KN; Guan H; Singh NP; Busbee B; Gandy A; Mehrpouya-Bahrami P; Ganewatta MS; Tang C; Chatterjee S; Nagarkatti P; Nagarkatti M
    Eur J Immunol; 2017 Jul; 47(7):1188-1199. PubMed ID: 28543188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L; Song Y; Li M
    J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
    Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
    Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Bactrian camel milk on the gut microbiota.
    Wang Z; Zhang W; Wang B; Zhang F; Shao Y
    J Dairy Sci; 2018 Jul; 101(7):5758-5769. PubMed ID: 29705422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
    Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
    J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis.
    Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q
    J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of Gut Microbiota in Patients With Graves' Disease.
    Chang SC; Lin SF; Chen ST; Chang PY; Yeh YM; Lo FS; Lu JJ
    Front Cell Infect Microbiol; 2021; 11():663131. PubMed ID: 34026662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model.
    Sun BL; Li WW; Wang J; Xu YL; Sun HL; Tian DY; Wang YJ; Yao XQ
    J Alzheimers Dis; 2019; 70(2):399-412. PubMed ID: 31177213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbiome profiling in systemic sclerosis: a metagenomic approach.
    Tan TC; Chandrasekaran L; Leung YY; Purbojati R; Pettersson S; Low AHL
    Clin Exp Rheumatol; 2023 Aug; 41(8):1578-1588. PubMed ID: 36826808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of gut microbiota in association with cholesterol gallstone formation in mice.
    Wang Q; Jiao L; He C; Sun H; Cai Q; Han T; Hu H
    BMC Gastroenterol; 2017 Jun; 17(1):74. PubMed ID: 28599622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis.
    Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S
    Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Miura S; Toyama T; Takahashi T; Ichimura Y; Yoshizaki A; Trojanowska M; Sato S
    J Invest Dermatol; 2017 Mar; 137(3):631-640. PubMed ID: 27777101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
    Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometriosis induces gut microbiota alterations in mice.
    Yuan M; Li D; Zhang Z; Sun H; An M; Wang G
    Hum Reprod; 2018 Apr; 33(4):607-616. PubMed ID: 29462324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights on chemically induced animal models of systemic sclerosis.
    Batteux F; Kavian N; Servettaz A
    Curr Opin Rheumatol; 2011 Nov; 23(6):511-8. PubMed ID: 21857225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dioxin-like PCB 126 increases intestinal inflammation and disrupts gut microbiota and metabolic homeostasis.
    Petriello MC; Hoffman JB; Vsevolozhskaya O; Morris AJ; Hennig B
    Environ Pollut; 2018 Nov; 242(Pt A):1022-1032. PubMed ID: 30373033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men.
    Kim AH; Lee Y; Kim E; Ji SC; Chung JY; Cho JY
    Front Cell Infect Microbiol; 2021; 11():629438. PubMed ID: 34123865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota.
    Groves HT; Cuthbertson L; James P; Moffatt MF; Cox MJ; Tregoning JS
    Front Immunol; 2018; 9():182. PubMed ID: 29483910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.